SPOTLIGHT: Phillipines courts Indian pharma

by admin |

Please, please, please bring your plants here. The Phillipines is targeting India's fast-growing pharma industry with tax incentives and duty exemptions, hoping to get more cheap drugs into the hands of its poor. President Gloria Macapagal-Arroyo announced the investment incentives in Mumbai, saying her country is "bullish on 21st century India." Welcome to the party, Madam President. Report

Suggested Articles

Pfizer building
Pharma

Pfizer's Vyndaqel off and running thanks to diagnosis push

Pfizer's diagnosis-focused launch strategy for Vyndaqel and Vyndamax is paying off with the meds reaching thousands of patients already.

by Eric Sagonowsky
Bavencio
Marketing

Pfizer nixes multiple Bavencio tests

Pfizer terminated a slew of trial cohorts testing Bavencio in combination with its own experimental drugs, as well as one monotherapy trial.

by Angus Liu
Jakafi
Pharma

Incyte doubles down on dermatitis push with Jakafi trial win

With its Eli Lilly-partnered Olumiant nearing filing in atopic dermatitis, Incyte's other JAK med Jakafi is also looking for a win in that indication.

by Kyle Blankenship